ZA828574B - Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it - Google Patents
Bivalent foot and mouth disease and colibacillose vaccine and method of preparing itInfo
- Publication number
- ZA828574B ZA828574B ZA828574A ZA828574A ZA828574B ZA 828574 B ZA828574 B ZA 828574B ZA 828574 A ZA828574 A ZA 828574A ZA 828574 A ZA828574 A ZA 828574A ZA 828574 B ZA828574 B ZA 828574B
- Authority
- ZA
- South Africa
- Prior art keywords
- colibacillose
- bivalent
- vaccine
- foot
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8121676A FR2516385A1 (en) | 1981-11-19 | 1981-11-19 | ANTI-APHTEOUS AND ANTI-COLIBACILLARY VACCINE AND METHOD FOR PREPARING THE SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA828574B true ZA828574B (en) | 1984-03-28 |
Family
ID=9264165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA828574A ZA828574B (en) | 1981-11-19 | 1982-11-19 | Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0080412B1 (en) |
AR (1) | AR229624A1 (en) |
DE (1) | DE3264316D1 (en) |
ES (1) | ES517461A0 (en) |
FR (1) | FR2516385A1 (en) |
IN (1) | IN155663B (en) |
ZA (1) | ZA828574B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK219084D0 (en) * | 1984-05-02 | 1984-05-02 | Frederik Carl Peter Lindberg | ANTIGEN |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1488212A (en) * | 1964-06-22 | 1967-07-13 | Behringwerke Ag | Method for reducing the foot-and-mouth disease virus |
LU57465A1 (en) * | 1968-12-04 | 1970-06-04 | ||
US4140763A (en) * | 1976-09-08 | 1979-02-20 | The United States Of America As Represented By The Secretary Of Agriculture | Vaccine for foot and mouth disease |
US4298597A (en) * | 1979-09-04 | 1981-11-03 | University Of Saskatchewan | Vaccine for diarrhea caused by E. coli |
-
1981
- 1981-11-19 FR FR8121676A patent/FR2516385A1/en active Granted
-
1982
- 1982-11-18 EP EP82402104A patent/EP0080412B1/en not_active Expired
- 1982-11-18 DE DE8282402104T patent/DE3264316D1/en not_active Expired
- 1982-11-18 ES ES517461A patent/ES517461A0/en active Granted
- 1982-11-19 ZA ZA828574A patent/ZA828574B/en unknown
- 1982-11-19 AR AR291359A patent/AR229624A1/en active
-
1983
- 1983-01-13 IN IN54/CAL/83A patent/IN155663B/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2516385A1 (en) | 1983-05-20 |
FR2516385B1 (en) | 1984-02-10 |
AR229624A1 (en) | 1983-09-30 |
EP0080412A1 (en) | 1983-06-01 |
EP0080412B1 (en) | 1985-06-19 |
IN155663B (en) | 1985-02-23 |
ES8307499A1 (en) | 1983-08-01 |
ES517461A0 (en) | 1983-08-01 |
DE3264316D1 (en) | 1985-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2103622B (en) | Production of foot and mouth disease vaccine from microbially expressed antigens | |
GB8822749D0 (en) | Vaccine containing tumour antigens & adjuvants | |
PT77515B (en) | Immunogenic protein or peptide complex method of producing said complex and use thereof as an immune stimulant and as a vaccine | |
EP0283505A4 (en) | Vaccine and method of preparation. | |
IL68201A0 (en) | Peptides with the specificity of foot and mouth disease viral antigens and compositions and methods for treating animals using the same | |
NZ216362A (en) | Synthetic vaccine for foot and mouth disease | |
DE3276151D1 (en) | Oral vaccine for immunization against enteric disease | |
JPS57144227A (en) | Manufacture of b type hepatitis vaccine | |
DE3378251D1 (en) | Vaccine for the immunization of animals and men against toxoplasma gondii | |
ZA828574B (en) | Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it | |
AR243081A1 (en) | Synthetic vaccins against foot and mouth disease and their preparation process | |
AU573574B2 (en) | Immunogenic deteminants of foot and mouth disease virus | |
ZA824174B (en) | Production of foot and mouth disease vaccine from microbially expressed antigens thereof | |
ZW26082A1 (en) | Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it | |
IL66042A0 (en) | Production of foot and mouth disease vaccine from microbially expressed antigens thereof | |
IL65920A0 (en) | Vaccine and its preparation | |
PH24366A (en) | Synthetic vaccines for foot and mouth disease | |
IE862645L (en) | Method of administering vaccines | |
ZA782613B (en) | Vaccine and method for immunotherapy of neoplastic disease | |
PL267231A1 (en) | Method of obtaining enzootic cattle leukaemia virus antigen | |
MN218A6 (en) | Method of preparing alumekatin medicinal preparation | |
IL62286A0 (en) | Preparation comprising glycyrhizin for the treatment of oral diseases | |
IL63338A0 (en) | Vaccine against bacterial diseases and its preparation | |
IL47784A (en) | Method for cultivating foot and mouth disease(fmd) virus | |
PH19948A (en) | Vaccines and method of preparation thereof |